Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Endocrinology · Prolactin-Producing Pituitary Tumor

Choosing Your Path: Treatment Options and Pregnancy Planning

At a Glance

The standard treatment for a prolactinoma is medication, such as cabergoline, which effectively shrinks the tumor, lowers prolactin levels, and restores fertility. If you are planning a pregnancy, your exact treatment plan will depend heavily on the size of your tumor.

Managing a prolactinoma is unique because, unlike most other tumors, the first-line treatment is almost always medication rather than surgery [1]. This is because the pituitary gland is highly sensitive to certain chemicals that can effectively “turn off” the tumor’s growth and hormone production.

The First Line: Dopamine Agonists

The standard treatment involves a class of drugs called dopamine agonists (DAs) [1]. These medications mimic the brain’s natural “off switch” for prolactin production.

  • Cabergoline: Often the preferred choice because it is more effective at normalizing prolactin levels and shrinking the tumor with fewer side effects [1][2]. It is typically taken only once or twice a week.
  • Bromocriptine: An older medication that is usually taken daily. While effective, it is more likely to cause side effects. It has a very long track record of safety in pregnancy [3][4].
  • How they work: These pills can cause the tumor to shrink significantly and bring prolactin levels back to normal, restoring fertility and sex drive [1][3].
  • Vision Recovery: If a large tumor is pressing on your optic nerves and affecting your vision, dopamine agonists can often rapidly shrink the tumor and decompress the nerve, restoring your peripheral vision without the need for surgery [5].
  • Timelines: Your doctor will likely order a follow-up blood test about 4 to 6 weeks after you start the medication to see how your prolactin levels are responding [6].

Practical Tips for Starting Medication

When you first start taking a dopamine agonist, you may experience immediate physical side effects such as nausea, dizziness (especially when standing up quickly due to a drop in blood pressure), or fatigue [7].

  • Pro-Tip: To minimize nausea and dizziness, take your medication right before bedtime with a small snack. If the side effects feel unmanageable, contact your doctor—do not abruptly stop the medication on your own.

When Surgery Is the Better Option

While medication is the first step for most, transsphenoidal surgery (a procedure performed through the nose to reach the pituitary) is an important tool in specific cases [8]. Your care team might recommend surgery if:

  • Intolerance or Resistance: You cannot handle the side effects of the medication, or the tumor does not shrink and your vision is not restored [8][9].
  • Cystic Tumors: If the tumor is mostly a fluid-filled cyst, it may not respond well to pills and might need to be physically drained or removed [10].
  • Emergency Situations: If the tumor suddenly bleeds (pituitary apoplexy) or causes rapid vision loss, surgery is needed to quickly relieve pressure on the optic nerves [11][12].

Planning for Pregnancy

If you are hoping to become pregnant, a prolactinoma diagnosis requires careful coordination with your endocrinologist. The guidelines depend heavily on the size of your tumor [3][13].

  • Pre-Pregnancy: Most women use dopamine agonists to restore ovulation and achieve pregnancy [3].
  • Microprolactinomas (< 1 cm): Once pregnancy is confirmed, the standard guideline is to stop taking the medication [13]. The risk of a small tumor growing dangerously large during pregnancy is very low (less than 3%) [14].
  • Macroprolactinomas (>= 1 cm): The approach is different. Because larger tumors have an approximately 20-30% risk of symptomatic enlargement during pregnancy, your doctor may recommend continuing your medication throughout the pregnancy, or stopping it but monitoring you very closely with regular vision and clinical checks [15][13].

Finding Your Balance

Your treatment plan is not “one size fits all.” It depends on the size of your tumor, how bothersome your symptoms are, and whether you are currently trying to conceive. Current consensus emphasizes shared decision-making [16].

Back to Home

Common questions in this guide

Do I need surgery to remove my prolactinoma?
Most prolactinomas are treated effectively with medication. However, transsphenoidal surgery may be recommended if you cannot tolerate the medication side effects, if the tumor does not shrink, or if the tumor is mostly a fluid-filled cyst.
What are the common side effects of prolactinoma medication and how can I manage them?
Common side effects include nausea, dizziness, and fatigue. To help minimize these symptoms, it is highly recommended to take your medication right before bedtime with a small snack.
Can medication restore my vision if the tumor is pressing on my optic nerve?
Yes, medications called dopamine agonists can often rapidly shrink a large tumor. This relieves pressure on the optic nerves and can effectively restore your peripheral vision without the need for surgery.
Should I stop taking my prolactinoma medication if I get pregnant?
For small tumors under one centimeter, known as microprolactinomas, doctors typically recommend stopping medication once pregnancy is confirmed. The risk of these small tumors growing significantly during pregnancy is extremely low.
How is a macroprolactinoma managed during pregnancy?
Because larger tumors have a higher risk of symptomatic enlargement during pregnancy, your doctor may recommend continuing your medication throughout the pregnancy. Alternatively, you may stop the medication but undergo very close clinical and vision monitoring.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Should I start with cabergoline or bromocriptine, and how do they differ in terms of side effects and success rates?
  2. 2.When exactly will we run my first follow-up blood test to see if the medication is working?
  3. 3.If I am planning a pregnancy in the next year, should we adjust my treatment plan now?
  4. 4.Is my tumor a microprolactinoma or macroprolactinoma, and how does that affect my pregnancy plan?
  5. 5.Is my tumor cystic, and if so, does that make me a better candidate for surgery than medication?
  6. 6.If I need surgery, how many transsphenoidal procedures do you or your neurosurgical partner perform each year?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    The Role of Dopamine Agonists in Pituitary Adenomas.

    Giraldi EA, Ioachimescu AG

    Endocrinology and metabolism clinics of North America 2020; (49(3)):453-474 doi:10.1016/j.ecl.2020.05.006.

    PMID: 32741482
  2. 2

    Treatment of hyperprolactinemia: A single-institute experience.

    Chen TY, Lee CH, Yang MY, et al.

    Journal of the Chinese Medical Association : JCMA 2021; (84(11)):1019-1022 doi:10.1097/JCMA.0000000000000584.

    PMID: 34261980
  3. 3

    Prolactinoma and pregnancy: From the wish of conception to lactation.

    Maiter D

    Annales d'endocrinologie 2016; (77(2)):128-34.

    PMID: 27130071
  4. 4

    Pregnancy and Tumor Outcomes in Women with Prolactinoma.

    Araujo B, Belo S, Carvalho D

    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2017; (125(10)):642-648 doi:10.1055/s-0043-112861.

    PMID: 28704852
  5. 5

    Operative treatment of cystic prolactinomas: a retrospective study.

    Su W, He K, Yang Y, et al.

    BMC endocrine disorders 2023; (23(1)):99 doi:10.1186/s12902-023-01343-0.

    PMID: 37143054
  6. 6

    Natural history of pituitary carcinoma with metastasis to the cervical spine: illustrative case.

    Gamboa NT, Wilkerson C, Kundu B, et al.

    Journal of neurosurgery. Case lessons 2023; (5(3)).

    PMID: 36647250
  7. 7

    Management outcomes of prolactinoma: a retrospective study from Southern Iraq.

    Alobaidy HF, Alidrisi HA, Reman KA, et al.

    Journal of medicine and life 2025; (18(9)):869-877 doi:10.25122/jml-2025-0050.

    PMID: 41178903
  8. 8

    The Role of Surgery in the Management of Prolactinomas.

    Donoho DA, Laws ER

    Neurosurgery clinics of North America 2019; (30(4)):509-514 doi:10.1016/j.nec.2019.05.010.

    PMID: 31471058
  9. 9

    Clinical characteristics and surgical outcome of prolactinoma in patients under 14 years old.

    Zhao Y, Jin D, Lian W, et al.

    Medicine 2019; (98(6)):e14380 doi:10.1097/MD.0000000000014380.

    PMID: 30732174
  10. 10

    Significance of surgical management for cystic prolactinoma.

    Ogiwara T, Horiuchi T, Nagm A, et al.

    Pituitary 2017; (20(2)):225-230 doi:10.1007/s11102-016-0766-6.

    PMID: 27757801
  11. 11

    Giant Prolactinoma: Challenges in Management.

    Sharma S, Acharya M, Sherpa C

    AACE endocrinology and diabetes 2025; (12(4)):260-264 doi:10.1016/j.aed.2025.07.004.

    PMID: 41467148
  12. 12

    Pituitary Microadenoma Treated with Individualized Homeopathic Medicine: A Case Report.

    Mathur M

    Homeopathy : the journal of the Faculty of Homeopathy 2020; (109(4)):243-247 doi:10.1055/s-0040-1713383.

    PMID: 32862414
  13. 13

    How does pregnancy affect the patients with pituitary adenomas: a study on 113 pregnancies from Turkey.

    Karaca Z, Yarman S, Ozbas I, et al.

    Journal of endocrinological investigation 2018; (41(1)):129-141 doi:10.1007/s40618-017-0709-8.

    PMID: 28634705
  14. 14

    Disease Activity and Maternal-fetal Outcomes in Pregnant Women With Prolactinoma: A Systematic Review and Meta-analysis.

    Bandeira DB, Alves LS, Glezer A, et al.

    The Journal of clinical endocrinology and metabolism 2025; (110(4)):e1241-e1251 doi:10.1210/clinem/dgae821.

    PMID: 39584508
  15. 15

    Analysis of bromocriptine treatment in pregnant pituitary prolactinoma patients.

    Lian W, Liu N, Wang RZ, et al.

    Clinical and experimental obstetrics & gynecology 2017; (44(2)):203-207.

    PMID: 29746023
  16. 16

    Changes in the Options for Management of Prolactin Secreting Pituitary Adenomas.

    Iuliano SL, Bi WL, Laws ER

    Journal of neurological surgery. Part B, Skull base 2022; (83(Suppl 2)):e49-e53 doi:10.1055/s-0040-1722665.

    PMID: 35832945

This page provides educational information about prolactinoma treatments and pregnancy planning. It does not replace professional medical advice. Always consult your endocrinologist to tailor a specific treatment plan for your situation.

Get notified when new evidence is published on prolactin producing pituitary tumor.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.